Scholars Central

Conference abstractPublished 12 Jul 2018

Use of mesenchymal stem cells in anti-aging strategies

Authors: Xiao Dong Chen

University of Texas Health Science Center at San Antonio, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Autologous mesenchymal stem cell (MSC)-based therapies are preferable due to biosafety concerns. In addition, increasing evidence suggests that MSCs may not be immune privileged. However, the quantity and quality of MSCs decline with age and limit the effectiveness and regenerative potential of autologous MSC therapies in elderly patients. Interestingly, we have observed that a sub-population of MSCs (5-10% of the total population) from elderly donors possess a more â??youthfulâ?� phenotype. The activity of these â??youthfulâ?� cells in vivo may be deeply suppressed by the aging environment, and the viability of these cells is diminished by harmful factors released by neighboring senescent cells during expansion in culture. In this presentation, I will discuss principles for the use of MSCs in anti-aging, and specifically describe a novel strategy for isolating and expanding this â??youthfulâ?� subpopulation from elderly patients to bank large quantities of high quality autologous MSCs for treating age-related diseases.

Subjects

Engineering

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Tissue Science and Engineering
  • SubjectEngineering
  • BylineArticles whose byline prints “Xiao Dong Chen”